Fosun International’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-17,155
Closed -$767K 92
2022
Q1
$767K Sell
17,155
-3,410
-17% -$148K 0.07% 118
2021
Q4
$888K Hold
20,565
0.05% 136
2021
Q3
$903K Hold
20,565
0.05% 128
2021
Q2
$889K Sell
20,565
-1,420
-6% -$59.7K 0.05% 113
2021
Q1
$857K Buy
21,985
+6,185
+39% +$234K 0.07% 110
2020
Q4
$561 Buy
15,800
+6,445
+69% +$232K 0.04% 127
2020
Q3
$353K Hold
9,355
0.03% 147
2020
Q2
$324K Sell
9,355
-1,995
-18% -$71.8K 0.03% 163
2020
Q1
$359K Buy
11,350
+1,525
+16% +$59.6K 0.03% 133
2019
Q4
$444K Buy
9,825
+500
+5% +$20.9K 0.04% 158
2019
Q3
$376K Buy
9,325
+1,500
+19% +$63.6K 0.04% 168
2019
Q2
$328K Buy
7,825
+110
+1% +$4.23K 0.02% 251
2019
Q1
$293K Hold
7,715
0.02% 258
2018
Q4
$266K Buy
7,715
+1,500
+24% +$54.4K 0.02% 264
2018
Q3
$238K Buy
+6,215
New +$217K 0.01% 225

Other funds holding BSX

Fosun International's BSX Position: Q2 2022 in Review

Fosun International sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 17,155 shares — an estimated $767K sold.

Fosun International first reported a position in BSX in Q3 2018 and held it in 15 quarters. The position peaked at $903K in Q3 2021. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Fosun International reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • Fosun International sold 17,155 Boston Scientific shares in Q2 2022, an estimated $767K.
  • Fosun International first reported a position in Boston Scientific in Q3 2018 and held it in 15 quarters.
  • Fosun International's Boston Scientific position peaked at $903K in Q3 2021.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Fosun International's 13F filing for Q2 2022, filed 10 Aug 2022.